What Researchers Did
Researchers systematically reviewed reports concerning hyperbaric oxygen therapy as an adjunctive treatment for neurologic emergency and neurosurgical diseases.
What They Found
The review indicated favorable effects of hyperbaric oxygen therapy in ultra-acute brain ischemia and showed prolonged survival for patients with malignant gliomas when combined with radiotherapy. It also found that hyperbaric oxygen therapy enhances the effects of certain chemotherapeutic agents, controls radiation-induced brain injury, and improves wound infection after intracranial or spinal surgery.
What This Means for Canadian Patients
Canadian patients facing specific neurological emergencies or neurosurgical conditions might find hyperbaric oxygen therapy to be a beneficial adjunctive treatment option. This therapy could potentially improve outcomes for conditions such as brain ischemia, malignant gliomas, and post-surgical infections.
Canadian Relevance
This systematic review does not specify any direct Canadian connection or data.
Study Limitations
The review highlights the necessity for high-quality randomized controlled trials to thoroughly evaluate the short- and long-term risks and benefits of hyperbaric oxygen therapy.